.
.
.
.
Coronavirus

Coronavirus: UK approves Moderna COVID-19 vaccine, orders 10 mln doses

Published: Updated:

Britain’s medical regulator on Friday approved Moderna’s COVID-19 vaccine for use, the health ministry said, adding that it had agreed to purchase an additional 10 million doses of the shot as it eyed a spring rollout of the shot.

Read the latest updates in our dedicated coronavirus section.

Three COVID-19 vaccines have now been approved for use in Britain, with Pfizer/BioNTech’s shot and one developed by Oxford University and AstraZeneca already being rolled out.

Britain now has 17 million doses of Moderna’s vaccine on order, and supplies will begin to be delivered to the UK from spring once Moderna expands its production capability.

“We have already vaccinated nearly 1.5 million people across the UK and Moderna’s vaccine will allow us to accelerate our vaccination program even further once doses become available from the spring,” health minister Matt Hancock said.

Moderna’s vaccine was 94 percent effective in preventing disease in late stage clinical trials, and it has already been approved for use in the US, Canada and the European Union.

Read more:

EU doubles coronavirus vaccine deal with Pfizer-BioNTech to 600 mln doses

UAE cycling team of Tour champ Pogačar gets COVID-19 vaccine

UK minister says concerned about vaccine protection against S.African COVID variant